SecBot SecBot
6-K ·Filed Apr 22, 2026

EVAX

Evaxion A/S
NEUTRAL
Impact 3/10
Horizonweeks Processed6mo ago SEC0001171843-26-002632
Notable filing: 6-K
Actionable Insight • Neutral

Monitor future warrant issuances and potential convertible note offerings as these could lead to dilution or new debt. The changes are administrative and do not signal immediate financial moves.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$4.27
T+0 close · Apr 22, 2026 · via day close
Latest settled
−27.99%
T+60 · $3.08
Vs SPY
−32.77%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 22 $4.27entry
  2. T+1 · 7mo ago −0.47%α −0.07% · $4.25
  3. T+5 · 7mo ago 0.00%α −0.05% · $4.27
  4. T+20 · 6mo ago −6.79%α −9.96% · $3.98
  5. T+60 · 4mo ago −27.99%α −32.77% · $3.08
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Evaxion A/S held its Annual General Meeting on April 16, 2026, where shareholders approved amendments to the company's Articles of Association. The key changes include increasing the board's authorization to issue warrants for employee incentives to DKK 11.9 million and replacing a lapsed authorization with a new one to obtain loans via convertible notes worth up to DKK 73.5 million. The company's Articles of Association were updated to reflect these changes.

Key Facts

  • Annual General Meeting held on April 16, 2026.
  • Shareholders approved amendments to the Articles of Association.
  • Authorization to issue warrants for employee incentives increased to DKK 11.9 million.
  • New authorization to obtain loans via convertible notes up to DKK 73.5 million approved.
  • Articles of Association updated as of April 16, 2026.

Financial Impact

The amendments allow for potential future capital raises and employee incentives, but no immediate financial impact is reported.

dilutiondebt

Risk Factors

  • Future warrant exercises could dilute existing shareholders.
  • Convertible note offerings could increase the company's debt burden.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001171843-26-002632
Document: f6k_042126.htm0001171843-26-002632
Document: 0001171843-26-002632-index-headers.html0001171843-26-002632
Document: 0001171843-26-002632-index.html0001171843-26-002632
Document: 0001171843-26-002632.txt0001171843-26-002632

Track record

50 reports on EVAX

Performance horizon

7 of 11 bullish or bearish reports moved the stock their way by T+1. Best: +22.94% at T+5 after the Mar 5, 2026 report. 10 of 11 went positive at some point.

Filters
  1. Nov 12, 20264d ago 6-K Neutral 2/10 Entry $2.77 to $2.74 Now $2.77 −0.00% ▼ −1.08% −0.72% vs SPY
  2. Nov 12, 20264d ago Press Release Neutral 1/10 Entry $2.77 to $2.74 Now $2.77 −0.00% ▼ −1.08% −0.72% vs SPY
  3. Nov 9, 20267d ago 6-K / F-1/A / PRESS-RELEASE Neutral 3/10 Entry $2.75 to $2.86 Now $2.77 +0.73% ▲ +4.00% +4.37% vs SPY
  4. Nov 6, 202610d ago 6-K Neutral 4/10 Entry $3.00 to $2.75 Now $2.77 −7.67% ▼ −8.33% −10.70% vs SPY
  5. Nov 6, 202610d ago Press Release Neutral 4/10 Entry $3.00 to $2.75 Now $2.77 −7.67% ▼ −8.33% −10.70% vs SPY
  6. Nov 4, 202612d ago 6-K Neutral 3/10 Entry $2.97 to $2.76 Now $2.77 −6.73% ▼ −7.07% −2.66% vs SPY
  7. Nov 4, 202612d ago 6-K Neutral 3/10 Entry $2.97 to $2.76 Now $2.77 −6.73% ▼ −7.07% −2.66% vs SPY
  8. Nov 3, 202613d ago 6-K Neutral 4/10 Entry $2.96 to $2.97 Now $2.77 −6.42% ▲ +0.34% −1.31% vs SPY
  9. Oct 30, 202617d ago 6-K Neutral 2/10 Entry $2.93 to $2.92 Now $2.77 −5.46% ▼ −0.34% +0.14% vs SPY
  10. Oct 30, 202617d ago Press Release Neutral 3/10 Entry $2.93 to $2.92 Now $2.77 −5.46% ▼ −0.34% +0.14% vs SPY
Showing 10 of 50

US Market Status

Market Closed · Opens in 6h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 22, 2026